
An AI-designed antibody just reached Phase III trials, and two more labs are racing to follow
Generate Biomedicines has an AI-designed antibody in multiple Phase III asthma trials. Isomorphic Labs and Xaira are close behind. Here is what actually separates hype from a filed IND.










